Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

sarilumab

sarilumab
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Kevzara SOLUTION, SUBCUTANEOUS 150 mg/1.14 mL, 200 mg/1.14 mL      
Comments:

Classified as formulary restricted, for use as approved under COVID-19 Drug Protocol for Adults, if tocilizumab cannot be used or is not available.

Restricted to ID physicians for the management of COVID-19.

Inpatients should use own supply for other indications. Defer initiation to after discharge.

Reviewed: 12 Dec 2017, 28 April 2020 (COVID-19)

Last updated: Sep. 15, 2021






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved